home / stock / nonof / nonof news

NONOF News and Press, Novo-Nordisk A/S From 02/07/24

Stock Information
Company Name: Novo-Nordisk A/S
Stock Symbol: NONOF
Market: OTC
Website: novonordisk.com
Menu
NONOF NONOF Quote NONOF Short NONOF News NONOF Articles NONOF Message Board
Get NONOF Alerts

News, Short Squeeze, Breakout and More Instantly...
NONOF - Novo Nordisk CEO wins 13% raise amid soaring demand for weight loss drugs

2024-02-07 13:52:09 ET More on Novo Nordisk Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript Biotech And Pharma Diversification Pays Off Novo Nordisk: Outlook For Weight Loss Drugs In 2024 Lilly reportedly worried about impact of Catalent/Novo deal ...
NONOF - Amgen cut at Leerink on heavy obesity expectations

2024-02-07 09:34:00 ET More on Amgen Amgen Inc. (AMGN) Q4 2023 Earnings Call Transcript Amgen: Debt-Funded Buybacks Constrains Future Gains Per Share Amgen: Accelerating The Business And Dividend Growth Amgen Non-GAAP EPS of $4.71 beats by $0.12, revenue of $...

NONOF - Eli Lilly beats in Q4 as obesity drug sales blow past estimates

2024-02-06 07:25:47 ET More on Eli Lilly Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Biotech And Pharma Diversification Pays Off Eli Lilly: The Cupboard Is Fully Stocked Eli Lilly beats top-line and bottom-line estimates; ...

NONOF - Novo-Catalent deal to ease Wegovy supply concerns

2024-02-05 15:46:06 ET More on Catalent, Novo Nordisk, etc. Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript Biotech And Pharma Diversification Pays Off Novo Nordisk: Outlook For Weight Loss Drugs In 2024 Biggest stock movers today: Nvidia, Air Product...
NONOF - Eli Lilly Q4 results to highlight Zepbound uptake

2024-02-05 12:38:30 ET More on Eli Lilly Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Biotech And Pharma Diversification Pays Off Eli Lilly: The Cupboard Is Fully Stocked Eli Lilly sees highest intraday trade since November...

NONOF - AbbVie cites tailwinds to Botox business from weight loss drugs

2024-02-02 13:06:23 ET More on AbbVie AbbVie Q4 Earnings Preview: Few Clouds On Horizon Thanks To Masterful Management (Rating Upgrade) AbbVie Inc. (ABBV) JPMorgan 42nd Annual Healthcare Conference AbbVie: Still Expensive Despite The Great M&A Acumen AbbV...

NONOF - U.S. govt. sends opening bids for drugs selected for Medicare price negotiations

2024-02-01 10:13:39 ET More on Bristol-Myers, Johnson & Johnson, etc. Pfizer Is Down 54% From Highs, Now Yields 6.1% Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Pfizer: Reviewing Q4 Earnings, FY24 Guidance - Why I Disagree Wit...
NONOF - U.S. govt. sends opening bids for drugs selected for Medicare pricing negotiations

2024-02-01 10:13:39 ET More on Bristol-Myers Squibb, Johnson & Johnson, etc. Pfizer Is Down 54% From Highs, Now Yields 6.1% Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Pfizer: Reviewing Q4 Earnings, FY24 Guidance - Why I Disag...

NONOF - Lilly, Novo could be first trillion-dollar health stocks: world's largest sovereign wealth fund

2024-01-31 12:32:57 ET More on Eli Lilly, Novo Nordisk, etc. Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript Biotech And Pharma Diversification Pays Off Novo Nordisk: Outlook For Weight Loss Drugs In 2024 Novo Nordisk stock hits all-time high as Wegov...

NONOF - Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript

2024-01-31 11:58:09 ET Novo Nordisk A/S (NVO) Q4 2023 Earnings Conference Call January 31, 2024 07:00 AM ET Company Participants Daniel Bohsen - Head of Investor Relations Lars Fruergaard Jorgensen - President and Chief Executive Officer Camilla Sylvest - Executi...
Previous 10 Next 10